Precision radiation boosts kidney cancer treatment in new trial

NCT ID NCT06583070

First seen Jan 31, 2026 · Last updated May 05, 2026 · Updated 12 times

Summary

This study looks at adding a precise type of radiation called SABR to standard drug therapy (targeted therapy and immunotherapy) for people with kidney cancer that has come back or spread. The goal is to see if this combination can help control the cancer longer than drugs alone. The study will enroll 300 participants and track how long they live without the cancer getting worse.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RADIATION THERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Peking University First Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100034, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Peking University Third Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100091, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.